Table 2.
Antimicrobial resistance profile of clinical isolates of carbapenem-resistant K. pneumoniae from our hospital (February 2010–December 2013).
| Antibiotic/MIC (μg/mL) | Total | Carbapenemase | |
|---|---|---|---|
| no (%) | MBL/no | KPC/no | |
| IMP | |||
| >4 | 98 (100) | 9 | 89 |
| MER | |||
| >8 | 98 (100) | 9 | 89 |
| EPT | |||
| >8 | 98 (100) | 9 | 89 |
| GEN | |||
| >4 | 63 (64) | 6 | 57 |
| SXT | |||
| >40 | 30 (31) | 4 | 26 |
| CS | |||
| >2 | 1 (1) | — | 1 |
| TGC | |||
| >2 | 60 (61) | 6 | 54 |
| FEP | |||
| >4 | 98 (100) | 9 | 89 |
| CTX | |||
| >4 | 98 (100) | 9 | 89 |
| CAZ | |||
| >4 | 98 (100) | 9 | 89 |
| CIP | |||
| >1 | 96 (98) | 7 | 89 |
| LVX | |||
| >2 | 96 (98) | 7 | 89 |
IMP: imipenem; MER: meropenem; EPT: ertapenem; GEN: gentamicin; SXT: trimethoprim-sulfamethoxazole; CS: colistin; TGC: tigecycline; FEP: cefepime; CTX: cefotaxime; CAZ: ceftazidime; CIP: ciprofloxacin; LVX: levofloxacin.